価格表

在庫・価格 : 2025年04月26日 21時56分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-CXCL16, Mouse, Goat-Poly
データシート※最新のデータシートでない場合があります
AF503 RSDアールアンドディー システムズ
R&D Systems, Inc.
100 μg ¥101,000
(未発注)
追加

在庫・価格 : 2025年04月26日 21時56分 現在

Anti-CXCL16, Mouse, Goat-Poly

  • 商品コード:AF503
  • メーカー:RSD
  • 包装:100μg
  • 価格: ¥101,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Haas CS et al. Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis. Arthritis Rheum. 2006 Aug;54(8):2402-14
Haas CS et al
2006/01/01
Application: Neutralization, Sample Type: Homogenized Tissue - Protocol Included PubMed
2 Ueha S et al. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects. J. Leukoc. Biol. 2007 Jan;81(1):176-85
Ueha S et al
2007/01/01
Application: IHC Fresh/Frozen, Sample Type: Whole Tissue PubMed
3 Wu T et al. Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance. Arthritis Rheum. 2007 Mar;56(3):949-59
Wu T et al
2007/01/01
Species: Mouse, Application: IHC Unspecified, Sample type: Whole Tissue PubMed
4 Wu T et al. Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J. Immunol. 2007 Nov;179(10):7166-75
Wu T et al
2007/01/01
Species: Mouse, Application: IHC Unspecified, Sample type: Whole Tissue PubMed
5 Eberlein J et al. Comprehensive assessment of chemokine expression profiles by flow cytometry. J. Clin. Invest. 2010 Mar;120(3):907-23
Eberlein J et al
2010/01/01
Application: Flow Cytometry, Sample Type: Whole Cells PubMed
6 Zhang SR et al. IL-33 modulates inflammatory brain injury but exacerbates systemic immunosuppression following ischemic stroke. JCI Insight 2018 Sep;3(18)
Zhang SR et al
2018/01/01
PubMed
  • No.: 1
  • 文献情報:
    Haas CS et al. Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis. Arthritis Rheum. 2006 Aug;54(8):2402-14
    Haas CS et al
    2006/01/01
  • 備考:
    Application: Neutralization, Sample Type: Homogenized Tissue - Protocol Included
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Ueha S et al. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects. J. Leukoc. Biol. 2007 Jan;81(1):176-85
    Ueha S et al
    2007/01/01
  • 備考:
    Application: IHC Fresh/Frozen, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Wu T et al. Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance. Arthritis Rheum. 2007 Mar;56(3):949-59
    Wu T et al
    2007/01/01
  • 備考:
    Species: Mouse, Application: IHC Unspecified, Sample type: Whole Tissue
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Wu T et al. Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J. Immunol. 2007 Nov;179(10):7166-75
    Wu T et al
    2007/01/01
  • 備考:
    Species: Mouse, Application: IHC Unspecified, Sample type: Whole Tissue
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Eberlein J et al. Comprehensive assessment of chemokine expression profiles by flow cytometry. J. Clin. Invest. 2010 Mar;120(3):907-23
    Eberlein J et al
    2010/01/01
  • 備考:
    Application: Flow Cytometry, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Zhang SR et al. IL-33 modulates inflammatory brain injury but exacerbates systemic immunosuppression following ischemic stroke. JCI Insight 2018 Sep;3(18)
    Zhang SR et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed